
|Articles|October 25, 2022
AAPS Conference Highlights 2022
Author(s)Alivia Leon
Advertisement
At the AAPS 2022 conference in Boston, BioPharm International interviewed Vibha Jawa, executive director at Bristol Myers Squibb, and Luke Schenck, principal scientist at Merck & Co. We spoke with Vibha Jawa about her expertise in the field of cell & gene therapies, specifically CAR-T cells. Luke Schenck discussed his knowledge on co-processed APIs. To see the highlights of our interviews with these experts, click the video below.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
2
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
3
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
4
Conjugation and Regulation Challenges for Advanced Molecules: Part Two of Three with Abzena
5




